9 March 2021
Dechra Pharmaceuticals PLC
(the Company)
Notification of Transactions by Persons Discharging Managerial Responsibilities
Dechra Pharmaceuticals PLC has been notified that on 9 March 2021 Alison Platt, Non-Executive Director, purchased 603 ordinary shares in the Company.
Following this acquisition, Alison Platt's beneficial interest in the Company is 1,363 shares (0.001% of the current issued share capital).
The Notification of Dealing Form set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.
Notification of Dealing Form
| 1. | Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") | ||
| a) | Name | Alison Platt
| |
| 2. | Reason for the notification | ||
| a) | Position/status | Director
| |
| b) | Initial notification/ amendment | Initial Notification | |
| 3. | Details of the Issuer | ||
| a) | Name | Dechra Pharmaceuticals PLC | |
| b) | LEI code | 213800J4UVB5OWG8VX82 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument
Identification code | Ordinary Shares of 1 pence each
ISIN: GB0009633180 | |
| b) | Nature of the transaction | Purchase of Shares | |
| c) | Price(s) and volumes(s) | Price(s) £32.905000 |
603 |
| d) | Aggregated information - Aggregate volume - Price - Total |
603
£32.905000 £19,841.72 | |
| e) | Date of the transaction | 2021-03-09 | |
| f) | Place of the transaction | London Stock Exchange | |
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
